IRIS
LANNI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.830
AS - Asia 5.478
EU - Europa 4.844
SA - Sud America 708
AF - Africa 154
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 5
Totale 18.038
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.677
CN - Cina 2.757
SG - Singapore 1.201
IE - Irlanda 1.173
UA - Ucraina 706
DE - Germania 598
HK - Hong Kong 582
FI - Finlandia 533
BR - Brasile 522
IT - Italia 469
RU - Federazione Russa 450
VN - Vietnam 414
FR - Francia 344
GB - Regno Unito 232
SE - Svezia 167
IN - India 130
CA - Canada 81
ZA - Sudafrica 80
AR - Argentina 73
BD - Bangladesh 61
JP - Giappone 53
MX - Messico 45
PK - Pakistan 34
EC - Ecuador 30
IQ - Iraq 29
TR - Turchia 27
ES - Italia 25
NL - Olanda 25
CO - Colombia 23
ID - Indonesia 23
BE - Belgio 20
PL - Polonia 20
SA - Arabia Saudita 19
VE - Venezuela 18
PH - Filippine 16
UZ - Uzbekistan 16
AT - Austria 15
TN - Tunisia 14
MY - Malesia 13
NZ - Nuova Zelanda 13
CZ - Repubblica Ceca 11
PY - Paraguay 11
AZ - Azerbaigian 10
CL - Cile 10
IR - Iran 10
JO - Giordania 10
PE - Perù 10
MA - Marocco 9
DZ - Algeria 8
EG - Egitto 8
JM - Giamaica 8
KZ - Kazakistan 7
NP - Nepal 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
BO - Bolivia 6
IL - Israele 6
KE - Kenya 6
KR - Corea 6
LT - Lituania 6
OM - Oman 6
CH - Svizzera 5
CR - Costa Rica 5
MU - Mauritius 5
PT - Portogallo 5
TH - Thailandia 5
BH - Bahrain 4
CG - Congo 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
LB - Libano 4
MD - Moldavia 4
RO - Romania 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
XK - ???statistics.table.value.countryCode.XK??? 4
AL - Albania 3
GE - Georgia 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
PA - Panama 3
PS - Palestinian Territory 3
AO - Angola 2
BG - Bulgaria 2
BJ - Benin 2
BY - Bielorussia 2
GR - Grecia 2
IS - Islanda 2
LV - Lettonia 2
MK - Macedonia 2
ML - Mali 2
MN - Mongolia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
Totale 18.016
Salva come PNG Salva come JPEG
Città #
Dublin 1.171
Chandler 997
Jacksonville 827
Singapore 630
Nanjing 579
Hong Kong 572
San Jose 572
Ashburn 561
Beijing 436
Dallas 361
Boardman 311
Nanchang 251
Shenyang 201
Princeton 195
Lawrence 191
Medford 187
Lauterbourg 165
Wilmington 164
Los Angeles 163
Helsinki 160
Jiaxing 144
Hebei 142
Munich 140
Changsha 139
Ho Chi Minh City 130
Tianjin 114
Pavia 107
Hangzhou 92
Shanghai 89
Hanoi 88
Ann Arbor 85
Buffalo 85
New York 83
Milan 75
Johannesburg 70
Moscow 70
Redondo Beach 66
Turku 57
São Paulo 56
Verona 47
Woodbridge 45
Tokyo 44
Orem 43
Frankfurt am Main 36
Norwalk 35
Council Bluffs 34
Chennai 31
Santa Clara 31
Montreal 30
Toronto 30
Falkenstein 26
The Dalles 25
Chicago 23
Da Nang 23
San Francisco 23
Seattle 22
Guangzhou 21
Houston 21
Washington 21
Brussels 20
London 20
Manchester 20
Boston 19
Denver 19
Haiphong 18
Rio de Janeiro 18
Stockholm 18
Brooklyn 17
Des Moines 17
Nuremberg 17
Pune 16
Zhengzhou 16
Tashkent 15
Baghdad 14
Brescia 14
Dearborn 14
Dong Ket 14
Mumbai 14
Phoenix 14
Amsterdam 13
Fairfield 13
Jakarta 13
Kunming 13
Warsaw 13
Atlanta 12
Dhaka 12
Jeddah 12
Jinan 12
Palmerston North 12
Rome 12
Columbus 11
Brasília 10
Changchun 10
Guayaquil 10
Lahore 10
Ningbo 10
Rodano 10
Tunis 10
Amman 9
Baku 9
Totale 11.707
Salva come PNG Salva come JPEG
Nome #
L'ipotesi della cascata amiloide nella malattia di Alzheimer: studi su strategie di neuroprotezione. 198
A composite nanosystem as a potential tool for the local treatment of glioblastoma: Chitosan‐coated solid lipid nanoparticles embedded in electrospun nanofibers 151
Antiradical Activity of Water solubile Components of Common Diet Vegetables 145
A novel pathway based on the recruitment of casein kinase 2 is involved in APP processing following cholinergic stimulation. 144
Beta-amyloid short- and long-term synaptic entanglement 142
Advances in understanding the pathogenetic mechanisms of Alzheimer's disease 141
Anti-hydroxyl radical activity of common edible vegetables 140
Acetylcholinesterase inhibitors: effects on pharmacological regulation of amyloid precursor protein processing 138
Amyloid beta-Protein (Abeta) Assembly: Abeta 1-40 And Abeta 1-42 different behaviour in the aggregation process 135
An integrated strategy to correlate aggregation state, structure and toxicity of Aß 1–42 oligomers 130
Depression and antidepressants: molecular and cellular aspects. 129
Anti-hydroxyl radical activity of common edible vegetables 129
Depressione: le nuove ipotesi sulle basi biologiche e il razionale di impiego e sviluppo dei farmaci antidepressivi 125
Antiradical activity of vegetables commonly included in the mediterranean diet 125
Characterization of the antioxidant effects of γ-oryzanol: Involvement of the Nrf2 Pathway 125
DNA damage accumulation and efficiency of DNA repair process in Down syndrome cell model systems 123
Capillary electrophoresis studies on the aggregation process of beta-amyloid 1-42 and 1-40 peptides 122
Appreciation of functional rather than lesional effects of beta amyloid (AB): a study on dopamine release following in vivo AB infusion 122
Proliferation characteristics and polyploidization of cultured myofibroblasts from a patient with fibroblastic rheumatism 121
The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disorders. 120
Acute beta-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens 120
Derivati antracenedionici e aza-antracenedionici come agenti capaci di inibire l’aggregazione di peptidi beta amiloidi 119
Acetylcholinesterase inhibitors modulate the metabolism of the amyloid precursor protein via different cellular mechanisms. 119
Acetylcholinesterase inhibitors: novel activities of old molecules 118
Altered DNA damage response in Down syndrome cells 115
Alterazioni vascolari e demenza: considerazioni sui possibili meccanismi biologici 114
Dehydroepiandrosterone and cortisol: effects on GNB2L1 human promoter region coding for RACK-1 scaffold protein. 114
Alzheimer's disease: new diagnostic and therapeutic tools 114
A novel composite nanosystem as a potential tool for the local treatment of glioblastoma. 113
Nicotinic component of galantamine in the regulation of amyloid precursor protein processing 113
Beta-amyloid: a disease target or a synaptic regulator affecting age-related neurotransmitter changes? 113
Prenylated curcumin analogues as multipotent tools to tackle Alzheimer's disease 113
APP processing: some details of downstream cholinergic stimulation. 112
Attività antiradicalica del caffè verde e tostato 111
Dopare il cervello 111
Role of b-amyloid in the pathophysiology of Alzheimer’s disease and cholinesterase inhibition: facing the biological complexity to treat the disease. 111
Unfolded p53 in blood as a predictive signature signature of the transition from mild cognitive impairment to Alzheimer's disease. 111
APP intracellular C-terminal domain function is related to its degradation process. 110
Dangerous liaisons between Beta-amyloid and cholinergic neurotransmission” 110
Studies on neuroprotective strategy based on the Amyloid Cascade Hypothesis 109
COGNITION ENHANCERS BETWEEN TREATING AND DOPING THE MIND 108
Antagonismo dei recettori NMDA: una nuova strategia per la neuroprotezione ed il trattamento delle demenze 108
Presence and passage-dependent loss of biochemical M3-muscarinic receptor function in human detrusor cultured smooth muscle cells 108
Role of spliceosome proteins in the regulation of glucocorticoid receptor isoforms by cortisol and dehydroepiandrosterone 108
Alternative views on beta amyloid: a disease target or a cell neuromodulator at the edge between signalling and degeneration. 107
Antagonismo dei recettori NMDA: una nuova strategia per la neuroprotezione ed il trattamento delle demenze 107
beta-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain. 106
Zyxin is a novel target for beta-amyloid peptide: characterisation of its role in Alzheimer pathogenesis 106
(Dys)regulation of Synaptic Activity and Neurotransmitter Release by β-Amyloid: A Look Beyond Alzheimer's Disease Pathogenesis 106
Galantamine: effect on the pharmacological regulation of the amyloid B precursor protein processing 105
Wild type but not mutant APP is involved in protective adaptive responses against oxidants. 104
In vitro and ex vivo antihydroxyl radical activity of green and dark roasted coffee 104
Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer's Disease: A Rational Approach 104
Regulation amyloid precursor protein processing: nicotinic component of galantamine 103
Conformational Altered p53 as an Early Marker of Oxidative Stress in Alzheimer's Disease. 103
Amyloid-β and Synaptic Vesicle Dynamics: A Cacophonic Orchestra. 103
Modulation of Rack-1/PKCβII signalling by soluble AβPPα in SH-SY5Y cells. 102
Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link? 102
Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer's disease patients. 101
Vegetable extracts protect IMR32 cells against H2O2 induced toxicity 101
Conformational altered p53 affects neuronal function: relevance for the response to toxic insult and growth-associated protein 43 expression 101
Different Effects of Beta-Amyloid on α7 and α4β2 Nicotinic Receptors Controlling the Release of Aminoacids in Rat Hippocampus 100
Conformational mutant isoform of p53 in blood peripheral cells: a putative marker for Alzheimer's disease 99
Vegetable extracts protect IMR32 cells against H2O2 induced toxicity 99
Nature-inspired Nrf2 activators in retinal pigment epithelial cells: a source for therapeutics in Age-related Macular Degeneration 99
Discovery of Abeta protein fibrillogenesis inhibitors by using CE. 98
Zyxin is a novel target for beta-amyloid peptide: characterization of its role in Alzheimer pathogenesis. 98
Emerging aspects of Alzheimer's disease (AD) pharmacotherapy and relationships with the underlying pathogenetic mechanisms 98
Capillary electrophoresis separation of metastable intermediates of amyloid protein fibrillogenesis to use them as independent targets for small molecules. 98
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2 98
Opposing effects of cortisol and dehydroepiandrosterone on the expression of the receptor for Activated C Kinase 1: implications in immunosenescence. 97
Culture primarie di muscolatura liscia di vescica come tool farmacologico per lo studio della trasmissione delle vie colinergiche nell'uomo. 97
Homeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival. 97
Galantamina, razionale farmacologico 96
PCK alfa recruitment of neural Elav proteins: implication for mRNA stability and translation 96
Basi neurobiologiche del ritardo mentale 96
Beta amyloid infusion impairs dopamine release in the nucleus accumbens. 96
Transcriptional regulation of RACK1 and modulation of its expression: Role of steroid hormones and significance in health and aging 96
Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease 96
Transizione conformazionale di proteine fibrillari e neurodegenerazione 95
Role of hormones in the regulation of RACK1 expression as a signaling checkpoint in immunosenescence 95
Role of acetylcholinesterase inhibitors in the pharmacological regulation of amyloid precursor protein processing 94
Galantamina: il farmaco e il contesto 94
Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule? 94
Effect of beta-amyloid infusion on dopamine release in limbic and motor dopaminergic areas 93
Capillary electrophoresis studies on the aggregation process of abeta 1-42 and abeta 1-40 peptides 93
Endothelin B receptor antagonists block proliferation and induce apoptosis in glioma cells 93
Role of protein kinase C alfa in the regulated metabolism of the amyloid precursor protein 92
Identification of a conformational mutant isoform of P53 in fibroblasts from sporadic Alzheimer¿s disease patients 92
AβPP Intracellular C-Terminal Domain Function is Related to its Degradation Processes 92
Defective DNA repair and increased chromatin binding of DNA repair factors in Down syndrome fibroblasts. 92
Silk Fibroin Nanoparticle Functionalized with Arg-Gly-Asp cyclopentapeptide: Tumor specific Active Targeting 92
Conformational mutant p53 isoform: a novel Alzheimer’s disease marker? 91
Antoxidant activities of coffee and common diet vegetables: some suggestions for a healthy aging 91
PKC alpha/ELAV-LIKE PROTEINS/GAP-43: A NEW CASCADE OF ACTIVATION IN SH-SY5Y CELLS 91
Eye-Light on Age-Related Macular Degeneration: Targeting Nrf2-Pathway as a Novel Therapeutic Strategy for Retinal Pigment Epithelium 91
Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathways 91
Nuove strategie terapeutiche nella demenza di Alzheimer 90
Attività antiradicalica dei componenti idrosolubili dei semi di Coffea robusta tostati 90
Targeting dementias through cancer kinases inhibition 90
Totale 10.862
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.939
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021371 0 0 0 0 0 0 0 0 0 175 156 40
2021/2022887 6 2 21 5 7 31 8 49 46 10 131 571
2022/20233.050 299 215 23 211 307 323 1 164 1.376 8 89 34
2023/2024995 126 161 40 100 104 224 24 78 9 66 27 36
2024/20252.660 51 248 80 98 42 145 92 214 631 85 310 664
2025/20265.488 478 427 619 654 705 339 1.136 243 493 394 0 0
Totale 18.298